US Stock MarketDetailed Quotes

EPIX ESSA Pharma

Watchlist

6.270
-0.120-1.88%

Close May 28 16:00 ET

278.16MMarket Cap-9952P/E (TTM)

ESSA Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

27.79%10.49M

-3.42%7.59M

-13.06%32.13M

0.39%7.15M

-4.09%8.91M

-28.39%8.21M

-13.42%7.86M

-0.49%36.96M

-22.73%7.12M

-0.64%9.29M

Selling and administrative expenses

16.75%4.54M

-6.11%2.42M

-7.44%11.37M

-24.63%2.09M

1.90%2.81M

4.39%3.89M

-14.80%2.58M

-3.88%12.28M

-5.04%2.77M

-10.75%2.76M

-General and administrative expense

16.75%4.54M

-6.11%2.42M

-7.44%11.37M

-24.63%2.09M

1.90%2.81M

4.39%3.89M

-14.80%2.58M

-3.88%12.28M

-5.04%2.77M

-10.75%2.76M

Research and development costs

37.87%6.18M

0.61%5.38M

-12.67%21.32M

20.10%5.23M

-1.93%6.27M

-41.42%4.48M

-11.22%5.34M

0.64%24.42M

-30.63%4.35M

2.61%6.39M

Depreciation amortization depletion

-42.59%-220.62K

----

-262.01%-154.73K

----

141.81%264.7K

-89.49%3.03K

432.17%135.72K

-Depreciation and amortization

-42.59%-220.62K

----

-262.01%-154.73K

----

141.81%264.7K

-89.49%3.03K

432.17%135.72K

Other operating expenses

----

-224.71%-207.1K

---554.4K

---162.9K

---172.99K

----

---63.78K

----

Operating profit

-27.79%-10.49M

3.42%-7.59M

13.06%-32.13M

-0.39%-7.15M

4.09%-8.91M

28.39%-8.21M

13.42%-7.86M

0.49%-36.96M

22.73%-7.12M

0.64%-9.29M

Net non-operating interest income expense

221.95%5.55M

119.92%1.67M

288.82%1.61M

-100.41%-1.94K

-103.34%-2.35K

709.72%1.72M

904.46%759.68K

550.79%414.73K

Non-operating interest income

----

219.80%5.55M

119.27%1.67M

286.25%1.61M

----

639.01%1.74M

856.58%762.43K

419.78%417.87K

Non-operating interest expense

--0

-49.50%6.94K

-59.24%1.12K

-51.45%1.53K

-44.87%1.94K

-45.66%2.35K

-38.14%13.75K

-32.48%2.75K

-81.13%3.15K

Other net income (expense)

30.23%1.5M

45.07%1.63M

-70.38%6.53K

88.08%-3.42K

-129.13%-827

761.84%1.15M

1,404.53%1.12M

-75.78%22.04K

-104.94%-28.65K

-99.47%2.84K

Gain on sale of security

30.23%1.5M

45.07%1.63M

-70.38%6.53K

88.08%-3.42K

-129.13%-827

761.84%1.15M

1,404.53%1.12M

-75.78%22.04K

-104.94%-28.65K

-99.47%2.84K

Income before tax

-27.36%-8.99M

11.53%-5.96M

24.52%-26.58M

14.22%-5.48M

17.74%-7.3M

34.97%-7.06M

25.90%-6.74M

4.41%-35.22M

25.34%-6.39M

-1.39%-8.87M

Income tax

101.43%1.6K

1.6K

-225.54%-111.82K

-66.15K

-5,820.88%-45.77K

Net income

-27.33%-8.99M

11.53%-5.96M

24.27%-26.58M

13.32%-5.48M

17.31%-7.3M

34.96%-7.06M

25.90%-6.74M

4.62%-35.1M

26.12%-6.32M

-0.85%-8.83M

Net income continuous Operations

-27.33%-8.99M

11.53%-5.96M

24.27%-26.58M

13.32%-5.48M

17.31%-7.3M

34.96%-7.06M

25.90%-6.74M

4.62%-35.1M

26.12%-6.32M

-0.85%-8.83M

Minority interest income

Net income attributable to the parent company

-27.33%-8.99M

11.53%-5.96M

24.27%-26.58M

13.32%-5.48M

17.31%-7.3M

34.96%-7.06M

25.90%-6.74M

4.62%-35.1M

26.12%-6.32M

-0.85%-8.83M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-27.33%-8.99M

11.53%-5.96M

24.27%-26.58M

13.32%-5.48M

17.31%-7.3M

34.96%-7.06M

25.90%-6.74M

4.62%-35.1M

26.12%-6.32M

-0.85%-8.83M

Basic earnings per share

-25.00%-0.2

6.67%-0.14

25.00%-0.6

14.29%-0.12

15.00%-0.17

36.00%-0.16

28.57%-0.15

16.67%-0.8

30.00%-0.14

4.76%-0.2

Diluted earnings per share

-25.00%-0.2

6.67%-0.14

25.00%-0.6

14.29%-0.12

15.00%-0.17

36.00%-0.16

28.57%-0.15

16.67%-0.8

30.00%-0.14

4.76%-0.2

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	27.79%10.49M	-3.42%7.59M	-13.06%32.13M	0.39%7.15M	-4.09%8.91M	-28.39%8.21M	-13.42%7.86M	-0.49%36.96M	-22.73%7.12M	-0.64%9.29M
Selling and administrative expenses	16.75%4.54M	-6.11%2.42M	-7.44%11.37M	-24.63%2.09M	1.90%2.81M	4.39%3.89M	-14.80%2.58M	-3.88%12.28M	-5.04%2.77M	-10.75%2.76M
-General and administrative expense	16.75%4.54M	-6.11%2.42M	-7.44%11.37M	-24.63%2.09M	1.90%2.81M	4.39%3.89M	-14.80%2.58M	-3.88%12.28M	-5.04%2.77M	-10.75%2.76M
Research and development costs	37.87%6.18M	0.61%5.38M	-12.67%21.32M	20.10%5.23M	-1.93%6.27M	-41.42%4.48M	-11.22%5.34M	0.64%24.42M	-30.63%4.35M	2.61%6.39M
Depreciation amortization depletion	-42.59%-220.62K	----	----	----	----	-262.01%-154.73K	----	141.81%264.7K	-89.49%3.03K	432.17%135.72K
-Depreciation and amortization	-42.59%-220.62K	----	----	----	----	-262.01%-154.73K	----	141.81%264.7K	-89.49%3.03K	432.17%135.72K
Other operating expenses	----	-224.71%-207.1K	---554.4K	---162.9K	---172.99K	----	---63.78K	----	----	----
Operating profit	-27.79%-10.49M	3.42%-7.59M	13.06%-32.13M	-0.39%-7.15M	4.09%-8.91M	28.39%-8.21M	13.42%-7.86M	0.49%-36.96M	22.73%-7.12M	0.64%-9.29M
Net non-operating interest income expense	0	0	221.95%5.55M	119.92%1.67M	288.82%1.61M	-100.41%-1.94K	-103.34%-2.35K	709.72%1.72M	904.46%759.68K	550.79%414.73K
Non-operating interest income	----	----	219.80%5.55M	119.27%1.67M	286.25%1.61M	----	----	639.01%1.74M	856.58%762.43K	419.78%417.87K
Non-operating interest expense	--0	--0	-49.50%6.94K	-59.24%1.12K	-51.45%1.53K	-44.87%1.94K	-45.66%2.35K	-38.14%13.75K	-32.48%2.75K	-81.13%3.15K
Other net income (expense)	30.23%1.5M	45.07%1.63M	-70.38%6.53K	88.08%-3.42K	-129.13%-827	761.84%1.15M	1,404.53%1.12M	-75.78%22.04K	-104.94%-28.65K	-99.47%2.84K
Gain on sale of security	30.23%1.5M	45.07%1.63M	-70.38%6.53K	88.08%-3.42K	-129.13%-827	761.84%1.15M	1,404.53%1.12M	-75.78%22.04K	-104.94%-28.65K	-99.47%2.84K
Income before tax	-27.36%-8.99M	11.53%-5.96M	24.52%-26.58M	14.22%-5.48M	17.74%-7.3M	34.97%-7.06M	25.90%-6.74M	4.41%-35.22M	25.34%-6.39M	-1.39%-8.87M
Income tax	0		101.43%1.6K	0	0	1.6K		-225.54%-111.82K	-66.15K	-5,820.88%-45.77K
Net income	-27.33%-8.99M	11.53%-5.96M	24.27%-26.58M	13.32%-5.48M	17.31%-7.3M	34.96%-7.06M	25.90%-6.74M	4.62%-35.1M	26.12%-6.32M	-0.85%-8.83M
Net income continuous Operations	-27.33%-8.99M	11.53%-5.96M	24.27%-26.58M	13.32%-5.48M	17.31%-7.3M	34.96%-7.06M	25.90%-6.74M	4.62%-35.1M	26.12%-6.32M	-0.85%-8.83M
Minority interest income
Net income attributable to the parent company	-27.33%-8.99M	11.53%-5.96M	24.27%-26.58M	13.32%-5.48M	17.31%-7.3M	34.96%-7.06M	25.90%-6.74M	4.62%-35.1M	26.12%-6.32M	-0.85%-8.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-27.33%-8.99M	11.53%-5.96M	24.27%-26.58M	13.32%-5.48M	17.31%-7.3M	34.96%-7.06M	25.90%-6.74M	4.62%-35.1M	26.12%-6.32M	-0.85%-8.83M
Basic earnings per share	-25.00%-0.2	6.67%-0.14	25.00%-0.6	14.29%-0.12	15.00%-0.17	36.00%-0.16	28.57%-0.15	16.67%-0.8	30.00%-0.14	4.76%-0.2
Diluted earnings per share	-25.00%-0.2	6.67%-0.14	25.00%-0.6	14.29%-0.12	15.00%-0.17	36.00%-0.16	28.57%-0.15	16.67%-0.8	30.00%-0.14	4.76%-0.2
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall